The Traderszone Network

Published in TZ Latest News 20 August, 2015 by The TZ Newswire Staff

This Is a Concern That Amgen Investors Shouldn’t Take Lightly

Most investors are focused on the upcoming PDUFA decision for PCSK9 inhibitor Repatha, but this should be a far bigger concern.